Interestingly, IL-6 and IL-1β have both been implicated in the dysregulation (altering the normal levels) of DMETs (Dunvald et al., 2022), and their presence in COVID-19 pathophysiology warrants a similar investigation. This evidence concerns the gene IL1B and COVID-19.